BRAIN & DEVELOPMENT, vol.40, no.10, pp.909-917, 2018 (SCI-Expanded)
Aim: Cryptogenic forms of epileptic encephalopathies (EE) with their well-known features of drug-resistance, mental deterioration and partial response to immunotherapies are ideal candidates for screening for neuronal autoantibodies (NAA).